A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

Author: Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Publisher: Elsevier

ISSN: 0920-1211

Source: Epilepsy Research, Vol.30, Iss.1, 1998-03, pp. : 31-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content